EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer

Kyukwang Kim iD, Negar Khazan, Jamie L McDowell, Cameron W A Snyder, John P Miller iD, Rakesh K Singh, Michelle E Whittum, Rachael Turner, Richard G Moore

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0314564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Kyukwang Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Signal Transduction, WAP Four-Disulfide Core Domain Protein 2, NF-kappa B. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer is the leading cause of death among gynecologic malignancies. Despite recent advancements in targeted therapies such as PARP inhibitors, recurrence is common and frequently resistant to existing therapies. A powerful diagnostic tool, coupled with a comprehensive understanding of its implications, is crucial. HE4, a clinical serum biomarker for ovarian cancer, has shown efficacy in monitoring malignant phenotypes, yet little is known about its biological role and regulatory mechanisms. Our research demonstrates that HE4 expression in ovarian cancer can be regulated by the NF-κB signaling pathway. We found that the activation of NF-κB signaling by tumor necrosis factor (TNF)-α, a cytokine found in ovarian cancer tumors and ascites, enhanced the secretion of HE4 while its inhibition suppressed HE4 levels. Nuclear translocation of the NF-κB component p65 was found to be critical for HE4 expression; induced NF-κB activation through p65 expression or constitutive IKK2 activity elevated HE4 expression, while p65 knockdown had the opposite effect. Furthermore, we observed that NF-κB mediated HE4 expression at the transcriptional level. Our data also suggests that there is a regulatory role for HE4 in the expression of α 5 -Integrin, a crucial adhesion molecule in ovarian cancer metastasis; HE4 knockdown corresponded with reduced α 5 -Integrin expression, cell migration and cell adhesion to fibronectin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsSignal TransductionWAP Four-Disulfide Core Domain Protein 2NF-kappa BHumansFemaleCell Line, TumorProteinsTumor Necrosis Factor-alphaCell MovementGene Expression Regulation, NeoplasticTranscription Factor RelAI-kappa B Kinase

Substanzen

WFDC2 protein, humanWAP Four-Disulfide Core Domain Protein 2NF-kappa BProteinsTumor Necrosis Factor-alphaTranscription Factor RelAI-kappa B Kinase

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, United States of America.
  • Department of Microbiology and Immunology, University of Rochester, Rochester, NY, United States of America.

ORCID-Profile: Kyukwang Kim, John P Miller

Zitieren

APA

Kim, K., Khazan, N., McDowell, J. L., Snyder, C. W. A., Miller, J. P., Singh, R. K., Whittum, M. E., Turner, R., & Moore, R. G. (2024). The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer. PLOS ONE. https://doi.org/10.1371/journal.pone.0314564

Vancouver

Kim K, Khazan N, McDowell JL, Snyder CWA, Miller JP, Singh RK, et al. The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer. PLOS ONE. 2024. doi:10.1371/journal.pone.0314564

BibTeX
@article{Kim2024,
  author = {Kim, Kyukwang and Khazan, Negar and McDowell, Jamie L and Snyder, Cameron W A and Miller, John P and Singh, Rakesh K and Whittum, Michelle E and Turner, Rachael and Moore, Richard G},
  title = {The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0314564}
}
Kostenlos starten →